Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: A pre-clinical study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: A pre-clinical study
Authors
Keywords
-
Journal
PROSTATE
Volume 77, Issue 16, Pages 1550-1562
Publisher
Wiley
Online
2017-10-03
DOI
10.1002/pros.23428
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Chemoprevention by Phytochemicals: Nature’s Healing Touch
- (2017) Haseeb Zubair et al. MOLECULES
- Stromal Androgen Receptor in Prostate Cancer Development and Progression
- (2017) Damien Leach et al. Cancers
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer
- (2016) Chad G. Rusthoven et al. JOURNAL OF CLINICAL ONCOLOGY
- Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro
- (2015) Han Qiao et al. ACTA PHARMACOLOGICA SINICA
- Cancer Therapy with Phytochemicals: Present and Future Perspectives
- (2015) Muobarak J. Tuorkey BIOMEDICAL AND ENVIRONMENTAL SCIENCES
- Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKC , Stat3, and Epithelial-to-Mesenchymal Transition Markers
- (2015) B. B. Hafeez et al. Cancer Prevention Research
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- 1,4-Naphthoquinones: From Oxidative Damage to Cellular and Inter-Cellular Signaling
- (2014) Lars-Oliver Klotz et al. MOLECULES
- Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects
- (2014) R Ferraldeschi et al. ONCOGENE
- Molecular Pathways: Targeting Resistance in the Androgen Receptor for Therapeutic Benefit
- (2013) E. A. Mostaghel et al. CLINICAL CANCER RESEARCH
- US Food and Drug Administration Approval of Drugs for the Treatment of Prostate Cancer: A New Era Has Begun
- (2013) Anthony V. D'Amico JOURNAL OF CLINICAL ONCOLOGY
- Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKC , Stat3 and neuroendocrine markers
- (2012) B. B. Hafeez et al. CARCINOGENESIS
- Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines
- (2012) Kuo-Pao Lai et al. EMBO Molecular Medicine
- Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cellsin vivo
- (2012) Sutapa Sinha et al. INTERNATIONAL JOURNAL OF CANCER
- Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
- (2012) Neil E Fleshner et al. LANCET
- Plumbagin, a medicinal plant (lumbago zeylanica )-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model
- (2012) Bilal Bin Hafeez et al. Molecular Oncology
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo
- (2012) Parisa Abedinpour et al. PROSTATE
- Sesame oil consumption exerts a beneficial effect on endothelial function in hypertensive men
- (2012) Kalliopi Karatzi et al. European Journal of Preventive Cardiology
- Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2
- (2011) Li Lai et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix: Comparison of Gonadotropin-Releasing Hormone Agonist and Antagonist Effect on Prostate Cancer
- (2011) E. David Crawford et al. JOURNAL OF UROLOGY
- Suppressed Prostate Epithelial Development with Impaired Branching Morphogenesis in Mice Lacking Stromal Fibromuscular Androgen Receptor
- (2011) Kuo-Pao Lai et al. MOLECULAR ENDOCRINOLOGY
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plumbagin enhances TRAIL-mediated apoptosis through up-regulation of death receptor in human melanoma A375 cells
- (2010) Jiawen Li et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Perspectives on medicinal properties of plumbagin and its analogs
- (2010) Subhash Padhye et al. MEDICINAL RESEARCH REVIEWS
- Plumbagin, a Medicinal Plant–Derived Naphthoquinone, Is a Novel Inhibitor of the Growth and Invasion of Hormone-Refractory Prostate Cancer
- (2008) Moammir H. Aziz et al. CANCER RESEARCH
- Genetic Background and the Dilemma of Translating Mouse Studies to Humans
- (2008) Juan Rivera et al. IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation